Over 10 years experience of Traceability Solutions

dsc  test  sandimmune  mg package image
April . 24 . 2020

Novartis recalls immunosuppressant Sandimmune, Neoral capsules for hazardous packaging

Novartis, like many generic drugmakers, was forced to pull copies of generic Zantac off shelves late last year after a carcinogen scare shocked the industry. Now, it’s…

CONTINUE READING
April . 21 . 2020

Potential new treatment for COVID-19 uncovered by BenevolentAI enters trials

BenevolentAI, a startup which has raised $292 million to apply AI to create drugs faster, today says it has uncovered an already approved drug as…

CONTINUE READING
GettyImages
Merck partners with AMCM on D printing wrbm large
April . 19 . 2020

Merck KGaA partners on 3D-printed tablets manufacture

A cooperation agreement will see Merck KGaA work with Additive Manufacturing Customized Machines (AMCM), a member of metals and polymers 3D printing company, EOS Group,…

CONTINUE READING
April . 16 . 2020

Drug discovery in the age of coronavirus

Developing new drugs is incredibly hard. That’s why, despite superhuman efforts from the industry, we’re still looking at 12-18 months minimum before we can realistically…

CONTINUE READING
corona
funds to beat corona
April . 14 . 2020

30 Top Stocks and Funds to Beat the COVID-19 Bear Market

With the Dow Jones Industrial Average, the Nasdaq Composite Index, and the S&P 500 all down by more than 20% from their recent highs, there’s no doubt that the…

CONTINUE READING
April . 12 . 2020

Firm works out ways to halt coronavirus replication with AI

Six unique plant molecules have shown the ability to halt the alarming multiplication of the SarsCoV-2 virus in an Artificial Intelligence (AI) modelling used by…

CONTINUE READING
corona replication
A man
April . 09 . 2020

Advanced Manufacturing’s Moment: Making Supplies For The War On COVID-19

It’s an all-hands – and robotic arms – on deck period in American history with manufacturers across the country leveraging technology to help combat COVID-19.…

CONTINUE READING
April . 08 . 2020

Patent processes should be adapted not circumvented

Circumventing patents to combat Covid-19 is understandable but does not encourage innovation at a time when innovation is needed most, argue Adv. Ephraim Heiliczer and…

CONTINUE READING
Ephraim Heiliczer and Dr. Tal Sines
Big Tech
April . 07 . 2020

Big Tech, Pharma Will Need PR for Post COVID-19 Backlash

Big technology and pharmaceutical companies will emerge from the chaos of the COVID-19 crisis even more powerful than they are today, according to The Economist,…

CONTINUE READING
April . 06 . 2020

Coronavirus Business Tracker: How The Private Sector Is Fighting The COVID-19 Pandemic

Businesses around the world are shifting into overdrive to help battle the coronavirus, providing everything from rubber gloves and ventilators to diagnostic tools and, hopefully…

CONTINUE READING
CoronavirusBusinessTracker:HowThePrivateSectorIsFightingTheCOVID Pandemic